Valentina Giorgio

Dr. Valentina Giorgio

Department of Life Sciences and Global Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
GCGiulia Catassi
Giulia Catassi
MAMarina Aloi
Marina Aloi
VGValentina Giorgio
Valentina Giorgio
Antonio GasbarriniAntonio Gasbarrini
Antonio Gasbarrini
GCGiovanni Cammarota
Giovanni Cammarota
Gianluca IaniroGianluca Ianiro
Gianluca Ianiro
The infant gut microbiome plays a key role in the healthy development of the human organism and appears to be influenced by dietary practices through multiple pathways. First, maternal diet during pregnancy and infant nutrition significantly influence the infant gut microbiota. Moreover, breastfeeding fosters the proliferation of beneficial bacteria, while formula feeding increases microbial diversity. The timing of introducing solid foods also influences gut microbiota composition. In preterm infants the gut microbiota development is influenced by multiple factors, including the time since birth and the intake of breast milk, and interventions such as probiotics and prebiotics supplementation show promising results in reducing morbidity and mortality in this population. These findings underscore the need for future research to understand the long-term health impacts of these interventions and for further strategies to enrich the gut microbiome of formula-fed and preterm infants.

20 April 2022 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ESELISABETTA SFORZA
ELISABETTA SFORZA
RORoberta Onesimo
Roberta Onesimo
CLchiara leoni
chiara leoni
VGValentina Giorgio
Valentina Giorgio
FPFrancesco Proli
Francesco Proli
GZGiuseppe Zampino
Giuseppe Zampino
Drooling, or sialorrhea, is a common condition in patients with cerebral palsy, rare diseases, and neurodevelopmental disorders. The goal of this review was to identify the different properties of sialorrhea outcome measures in children. Four databases were analysed in search of sialorrhea measurement tools, and the review was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement. The COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN) checklist was used for quality appraisal of the outcome measures. The initial search yielded 891 articles, 430 of which were duplicates. Thus, 461 full-text articles were evaluated. Among these, 21 met the inclusion criteria, reporting 19 different outcome measures that encompassed both quantitative measures and parent/proxy questionnaires.   Conclusions: Among the outcome measures found through this review, the 5-min Drooling Quotient can objectively discriminate sialorrhea frequency in patients with developmental disabilities. The Drooling Impact Scale can be used to evaluate changes after treatment. The modified drooling questionnaire can measure sialorrhea severity and its social acceptability. To date, the tests proposed in this review are the only tools displaying adequate measurement properties. The acquisition of new data about reliability, validity, and responsiveness of these tests will confirm our findings. What is Known:• Although sialorrhea is a recognized problem in children with disabilities, especially those with cerebral palsy (CP), there is a lack of confidence among physicians in measuring sialorrhea. What is New:• Few sialorrhea measures are available for clinicians that may guide decision-making and at the same time have strong evidence to provide confidence in the results.• A combination of both quantitative measures and parent/proxy questionnaires might provide an adequate measurement of sialorrhea in children.

8 March 2024 in Genes
Verified
Journal Article
Open access
PDF file
VTValentina Trevisan
Valentina Trevisan
AMAnna Meroni
Anna Meroni
CLchiara leoni
chiara leoni
FSFabio Sirchia
Fabio Sirchia
DPdavide politano
davide politano
RORoberta Onesimo
Roberta Onesimo
Background: Among aneuploidies compatible with life, trisomy 22 mosaicism is extremely rare, and only about 25 postnatal and 18 prenatal cases have been described in the literature so far. The condition is mainly characterized by facial and body asymmetry, cardiac heart defects, facial dysmorphisms, growth failure, delayed puberty, and variable degrees of neurodevelopmental delay. Problem: The scattered information regarding the condition and the dearth of data on its natural history and developmental outcomes restrict genetic counseling, particularly in prenatal settings. Moreover, a prompt diagnosis is frequently delayed by the negative selection of trisomic cells in blood, with mosaicism percentage varying among tissues, which often entails the need for further testing. Purpose/topic: The aim of our work is to provide assistance in prenatal and postnatal genetic counseling by systematically delineating the current knowledge of the condition. This entails defining the prenatal and postnatal characteristics of the condition and presenting novel data from three cases, both prenatally and postnatally. Additionally, we report the developmental outcomes observed in two new patients.

11 April 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
VGValentina Giorgio
Valentina Giorgio
GMGaia Margiotta
Gaia Margiotta
GSGiuseppe Stella
Giuseppe Stella
FCFederica Di Cicco
Federica Di Cicco
CLchiara leoni
chiara leoni
RORoberta Onesimo
Roberta Onesimo
Functional gastrointestinal disorders (FGIDs) are very common and life-impacting in children and young adults, covering 50% of pediatric gastroenterologist consultations. As it is known, FGIDs may be due to alterations in the gut–brain axis, dysbiosis and dysregulation of intestinal barrier, causing leaky gut. This may enhance increased antigen and bacterial passage through a damaged mucosa, worsening the impact of different medical conditions such as FGIDs. Little is known about the role of nutrients in modifying this “barrier disruption”. This narrative review aims to analyze the clinical evidence concerning diet and Intestinal Permeability (IP) in FGIDs in children. We searched the PubMed/Medline library for articles published between January 2000 and November 2021 including children aged 0–18 years old, using keywords related to the topic. Since diet induces changes in the intestinal barrier and microbiota, we aimed at clarifying how it is possible to modify IP in FGIDs by diet modulation, and how this can impact on gastrointestinal symptoms. We found that) is that small changes in eating habits, such as a low-FODMAP diet, an adequate intake of fiber and intestinal microbiota modulation by prebiotics and probiotics, seem to lead to big improvements in quality of life.

27 March 2022 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
Giovanni Di NardoGiovanni Di Nardo
Giovanni Di Nardo
CCCesare Cremon
Cesare Cremon
ASAnnamaria Staiano
Annamaria Staiano
VSVincenzo Stanghellini
Vincenzo Stanghellini
OBOsvaldo Borrelli
Osvaldo Borrelli
GBGiovanni Barbara
Giovanni Barbara

25 September 2023 in European Journal of Medical Genetics
Verified
Journal Article
Open access
RORoberta Onesimo
Roberta Onesimo
ESELISABETTA SFORZA
ELISABETTA SFORZA
MBMaria Francesca Bedeschi
Maria Francesca Bedeschi
CLchiara leoni
chiara leoni
VGValentina Giorgio
Valentina Giorgio
GZGiuseppe Zampino
Giuseppe Zampino
The clinical features of achondroplasia can cause acute self-limited pain that can evolve into chronic pain. Pain causes a low quality of life, in terms of physical, emotional, social, and school functioning in both adult and children with achondroplasia. We conducted a systematic review according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement to describe prevalence, assessment tools, causes and management strategies of pain in this rare disease. We found that shoulder and knee pain is typically referred during infancy, while knee pain is generally referred around 5-6 years of age. The prevalence of general pain in adolescence can be as high as 90%. Chronic pain in the achondroplasia population increases with age, with up to 70% of adults reporting general pain and back pain. Recognizing the multiple determinants of acute and chronic pain in patients with achondroplasia may enable physicians to better understand and manage this burden, particularly with the advent of new drugs that may modify some of the striking features of achondroplasia.